Home › NDC Lookup › RxCUI directory › RxCUI 1863354

2 ML vincristine sulfate 1 MG/ML Injection — RxCUI 1863354

Name: 2 ML vincristine sulfate 1 MG/ML Injection (RxCUI 1863354)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1863354 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1863354

Official name2 ML vincristine sulfate 1 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known as2 ML VCR Sulfate 1 MG/ML Injection; vinCRIStine sulfate 2 MG in 2 ML Injection; vincristine sulfate 2 MG per 2 ML Injection

FDA products mapped2

Package NDCs mapped4

Reported Medicaid activity (SDUD)9,198 prescriptions · 40 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vincristine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

This is genuinely one of the most important safety issues with this drug. Vincristine is safe when given correctly into a vein, but if it were accidentally injected into the spinal...
Why does my nurse make such a big deal about how vincristine is given?
Hair loss is the most common one, and it's usually temporary — hair often regrows even while treatment continues. Constipation is also very common, so your care team may recommend...
What side effects are most likely to happen to me?

📖 Read our full Vincristine Injection guide →

🕸️ Concept Web — How 2 ML vincristine sulfate 1 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML vincristine sulfate 1 MG/ML Injection RxCUI 1863354 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Vincristine 11202 IN
- Vincristine sulfate 11203 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vincasar 227575 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Vincristine Injection 1863342 SCDF
- Vincristine sulfate Injection 2648144 SCDFP
- Vincristine Injectable Product 1160531 SCDG
- Vincristine sulfate Injectable Product 2663552 SCDGP
- Vincristine Injection [Vincasar] 1863346 SBDF
- Vincristine sulfate Injection [Vincasar] 2654277 SBDFP
- Vincasar Injectable Product 1186612 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Vincristine sulfate 1 MG/ML 894892 SCDC
- 2 ML vincristine sulfate 1 MG/ML Injection [Vincasar] 1863355 SBD
- Vincristine sulfate 1 MG/ML [Vincasar] 894894 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Vincristine sulfate 1 MG/ML SCDC · 894892
Vincristine Injection SCDF · 1863342
Vincristine sulfate Injection SCDFP · 2648144
Vincristine Injectable Product SCDG · 1160531
Vincristine sulfate Injectable Product SCDGP · 2663552

Brand-Name Concepts

2 ML vincristine sulfate 1 MG/ML Injection [Vincasar] SBD · 1863355
Vincristine sulfate 1 MG/ML [Vincasar] SBDC · 894894
Vincristine Injection [Vincasar] SBDF · 1863346
Vincristine sulfate Injection [Vincasar] SBDFP · 2654277
Vincasar Injectable Product SBDG · 1186612
Vincasar BN · 227575

📦 FDA Products & Package NDCs

2 products · 4 package NDCs

4 package NDCs map to RxCUI 1863354 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
61703-0309-06	1 VIAL, SINGLE-DOSE in 1 CARTON (61703-309-06) / 1 mL in 1...	VinCRIStine Sulfate	Hospira, Inc.	1996-01-01
61703-0309-16	1 VIAL, SINGLE-DOSE in 1 CARTON (61703-309-16) / 2 mL in 1...	VinCRIStine Sulfate	Hospira, Inc.	1996-01-01
61703-0309-25	1 VIAL, SINGLE-DOSE in 1 CARTON (61703-309-25) / 2 mL in 1...	VinCRIStine Sulfate	Hospira, Inc.	2013-11-27
61703-0309-26	1 VIAL, SINGLE-DOSE in 1 CARTON (61703-309-26) / 1 mL in 1...	VinCRIStine Sulfate	Hospira, Inc.	2014-02-19

Observed labelers: Hospira, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9370	Vincristine sulfate 1 mg inj	4	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.